A Study of LY3023414 Formulations and the Effect of Food

NCT02818335 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3023414 Reference Fasted
DRUG: LY3023414 Test Fasted
DRUG: LY3023414 Test Fed

Sponsor

Eli Lilly and Company